Treace Medical Concepts, Inc. (TMCI) Operating cash flow 2019–2025
Treace Medical Concepts, Inc. (TMCI) annual operating cash flow history from SEC filings — net cash provided by operating activities each fiscal year.
-$16.0MFY2025 · since FY2019: -$7.7M → -$16.0M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$16.0M | +57.0% |
| FY2024 | -$37.2M | -7.5% |
| FY2023 | -$34.6M | -12.8% |
| FY2022 | -$30.6M | -78.3% |
| FY2021 | -$17.2M | -282.6% |
| FY2020 | -$4.5M | +41.4% |
| FY2019 | -$7.7M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More TMCI financial trends
TMCI RevenueTMCI Net incomeTMCI Net marginTMCI Gross profitTMCI Gross marginTMCI Operating incomeTMCI Operating marginTMCI Free cash flowTMCI Capital expendituresTMCI Return on equityTMCI Stock buybacksTMCI Dividends paidTMCI Total assetsTMCI Total liabilitiesTMCI Shareholders’ equityTMCI overview →